Image
![Southeast AETC Local Partner](/sites/default/files/styles/content_tiny/public/media/image/2022-02/SE-social-media-011122.png?itok=V6jpuiC4)
Training slides review how neutralizing antibodies (bNAbs) develop in people with HIV, identify the potential future uses of bNAbs to prevent, treat and/or cure HIV as well as the challenges in developing bNAbs for clinical use in the context of long-acting antiretroviral therapy.
Browse more